Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
News|Articles|January 1, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-01-01-2005
- Volume 17
- Issue 1
Dessicants for Pharmaceutical Applications
Author(s)Alan Newbold, Ian Buckley
This article examines the different types of dessicants avaliable to the pharmaceutical industry. It provides information on choosing the right type, and how and when it should be used.
Advertisement
Articles in this issue
almost 22 years ago
US Packaging Show Displays many Pharma Machinesalmost 22 years ago
The Seventh Annual International Employment Surveyalmost 22 years ago
Issues in the Appraisal of Laser Diffraction Particle Sizing Techniquesalmost 2022 years ago
The Use of Acrylic Resins for Improved Aqueous Enteric CoatingAdvertisement
Related to this article
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement